Marksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a record Rs 213 crore, driven by strong growth in its UK and Europe formulation businesses.
Marksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a record Rs 213 crore, driven by strong growth in its UK and Europe formulation businesses.
<iframe src="https://hindustansphere.com/embed/cluster/4325a880c255bf7930b4cdbd33574fccf578abd1" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Marksans Pharma shares rally over 9% after Q1 profit spikes 174% YoY to Rs 159 crore"></iframe>
